The AESKU HELIOS distributed by Grifols in the US, was showcased among 17 other cutting-edge healthcare products and groundbreaking startup companies on Tuesday night at its annual Innovation Celebration.
The Innovation Celebration featured next-generation healthcare products to support critical medical needs.
The HELIOS is a new revolutionary platform that employs automated immunofluorescence (IFA) technology to process and analyze patient samples. It is the first clinical diagnostics platform to offer automation of the IFA process to this extent.
The Innovation Celebration took place during Premier’s 2017 Breakthroughs Conference and Exhibition, a week-long event that brings together more than 4,000 representatives from hospitals and health systems, suppliers and other healthcare organizations to share best practices and proven methods to improve quality while safely reducing costs.